# 18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

> **NCT03824535** · PHASE2 · COMPLETED · sponsor: **Andrei Iagaru** · enrollment: 15 (actual)

## Conditions studied

- Cigarette Smoker
- Current Smoker
- Former Smoker
- Multiple Pulmonary Nodules
- Pulmonary Nodule

## Interventions

- **DIAGNOSTIC_TEST:** Computed Tomography
- **DRUG:** Fludeoxyglucose F-18
- **DRUG:** Fluorine F 18 L-glutamate Derivative BAY94-9392
- **DIAGNOSTIC_TEST:** Positron Emission Tomography (PET/CT)

## Key facts

- **NCT ID:** NCT03824535
- **Lead sponsor:** Andrei Iagaru
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-04
- **Primary completion:** 2021-07-30
- **Final completion:** 2021-07-30
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2025-04-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03824535

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03824535, "18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03824535. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*